Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/29/2871288/0/en/Outlook-Therapeutics-to-Present-at-the-Ophthalmology-Innovation-Summit-OIS-Retina-Innovation-Showcase.html
https://www.globenewswire.com/news-release/2024/04/15/2863165/0/en/Outlook-Therapeutics-Announces-Closing-of-Private-Placement-of-5-0-Million.html
https://www.globenewswire.com/news-release/2024/03/22/2850893/0/en/Outlook-Therapeutics-Receives-European-Union-Positive-CHMP-Opinion-for-ONS-5010-as-a-Treatment-for-Wet-AMD.html
https://www.globenewswire.com/news-release/2024/03/18/2848203/0/en/Outlook-Therapeutics-Announces-Closing-of-Private-Placement-of-up-to-159-Million.html
https://www.globenewswire.com//news-release/2024/03/12/2844498/0/en/Outlook-Therapeutics-Announces-Effective-Date-for-1-for-20-Reverse-Stock-Split.html
https://www.globenewswire.com//news-release/2024/02/14/2829061/0/en/Outlook-Therapeutics-Reports-Financial-Results-for-First-Quarter-Fiscal-Year-2024-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/01/31/2821094/0/en/Outlook-Therapeutics-Doses-First-Subject-in-NORSE-EIGHT.html
https://www.globenewswire.com//news-release/2024/01/23/2814047/0/en/Outlook-Therapeutics-Receives-FDA-Agreement-Under-Special-Protocol-Assessment-SPA-for-90-Day-Non-Inferiority-Study-NORSE-EIGHT-and-Announces-Private-Placement-of-Up-to-172-Million-.html
https://www.globenewswire.com/news-release/2023/12/22/2800574/0/en/Outlook-Therapeutics-Reports-Financial-Results-for-Fiscal-Year-2023-and-Reiterates-ONS-5010-Clinical-and-Regulatory-Path-Forward-in-the-U-S-and-EU.html
https://www.globenewswire.com//news-release/2023/12/19/2798509/0/en/Outlook-Therapeutics-Submits-Special-Protocol-Assessment-SPA-to-FDA-for-Non-Inferiority-Study-of-ONS-5010.html